Search Results for:

REDHAWK COMMENCES SALE OF BRANDED GENERICS TO CLINICAL COMMISSIONING GROUPS Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (“RedHawk” or the “Company”) announced today that EcoGen Europe Limited (“EcoGen”) has commenced the process of selling its branded generic pharmaceutical drugs to a Clinical Commissioning Group (“CCG”). Initial deliveries of EcoGen’s branded generics to this first…

Read More »

REDHAWK TO INCREASE ITS OWNERSHIP STAKE IN ECOGEN  February 23, 2017   Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (“RedHawk” or the “Company”) announced today that it has verbally agreed to increase its ownership position in EcoGen Europe Limited (“EcoGen”) to approximately 50%. The increase in RedHawk’s ownership position is subject to the completion…

Read More »

February 20, 2017   REDHAWK TO EXPAND INNOVATION CENTER OFFICES Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (“RedHawk” or the “Company”) announced today it is expanding its medical device warehousing and administrative offices at the Louisiana State University (“LSU”) Innovation Park (the “LSU Innovation Park”), a 200 plus acre university research park located five miles south of the main LSU campus in Baton Rouge, Louisiana. The Company said it hopes to complete the expansionof its innovation…

Read More »

December 22, 2016 WOUNDCLOT APPROVED FOR NHS SUPPLY CHAIN Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (“RedHawk” or the “Company”) announced today that all three of its WoundClot Surgical – Advanced Bleeding Control (“WoundClot”) offered products have been approved to participate in the Framework Agreement to Supply Wound Closure products, more commonly known as…

Read More »

REDHAWK TO EXIT REAL ESTATE INVESTMENTS   December 8, 2016   Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (“RedHawk” or the “Company”) announced today that it will exit its real estate investments beginning in 2017. The Company said that it has achieved satisfactory returns on these investments and believes the invested capital can now…

Read More »

REDHAWK ANNOUNCES FIRST QUARTER RESULTS  December 5, 2016   Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (“RedHawk” or the “Company”) announced today a consolidated net loss of $187,175 ($nil per share) on gross revenues of $499,280 for the three month period ended September 30, 2016. These first quarter results compare to a net loss…

Read More »

REDHAWK ANNOUNCES YEAR END RESULTS OCTOBER 31, 2016   Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (the “Company”) announced today a net loss of $1,267,960 ($nil per diluted share) on revenues of $29,450 for the fiscal year ended June 30, 2016. Included in the reported loss were certain non-recurring costs and expenses, including approximately…

Read More »

REDHAWK RECEIVES PRE-MARKET CLEARANCE FOR NEEDLE DESTRUCTION UNIT October 25, 2016    Youngsville, Louisiana – RedHawk Holdings Corp. (OTCQB: IDNG) (“RedHawk” or the “Company”) announced today it has completed the re-engineering of its Sharps and Needle Destruction Device (“SANDD”) and has received pre-market clearance from the U.S. Food and Drug Administration for the sale of…

Read More »

Form Type Received Period Ending Report NT 10-Q Feb 14, 2017 Dec 31, 2016 Form NT 10-Q Form 4 Feb 8, 2017 Feb 2, 2017 Form 4 Form 4 Jan 20, 2017 Jan 13, 2017 Form 4 Form 4 Jan 7, 2017 Jan 3, 2017 Form 4 Form 4 Dec 13, 2016 Dec 8, 2016…

Read More »